Search research articles
Contact Us
Filters
Showing results (391-400 of 682) with videos related to
Page
of 69
Sort By:
The New England Journal of Medicine
|
November 7, 1996
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1
S C Rubin, I Benjamin, K Behbakht, et al.
Cancer Research Communications
|
March 5, 2024
Health Care Access Dimensions and Racial Disparities in End-of-Life Care Quality among Patients with Ovarian Cancer
Shama Karanth, Oyomoare L Osazuwa-Peters, Lauren E Wilson, et al.
Gynecologic Oncology
|
November 13, 2023
High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancer
Katherine E Baumann, Sharareh Siamakpour-Reihani, Joseph Dottino, et al.
Oncogene
|
October 7, 2008
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
T Baba, P A Convery, N Matsumura, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 25, 2007
A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer
J D Wright, A A Secord, T M Numnum, et al.
Journal of Minimally Invasive Gynecology
|
October 12, 2014
Vaginal cuff thermal injury by mode of colpotomy at total laparoscopic hysterectomy: a randomized clinical trial
Deanna Teoh, William J Lowery, Xiaoyin Jiang, et al.
JAMA
|
January 24, 2023
Predictive Accuracy of Stroke Risk Prediction Models Across Black and White Race, Sex, and Age Groups
Chuan Hong, Michael J Pencina, Daniel M Wojdyla, et al.
European Urology
|
April 23, 2021
Impact of Pathogenic Germline DNA Damage Repair alterations on Response to Intense Neoadjuvant Androgen Deprivation Therapy in High-risk Localized Prostate Cancer
Jacob E Berchuck, Zhenwei Zhang, Rebecca Silver, et al.
Gynecologic Oncology
|
May 21, 2005
BRAF polymorphisms and the risk of ovarian cancer of low malignant potential
Livia Kelemen, Michael James, Amanda Spurdle, et al.
Gynecologic Oncology
|
January 16, 2020
Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer
K Bixel, M Vetter, B Davidson, et al.
Page
of 69
Search research articles
Search
Showing results (391-400 of 682) with videos related to
Sort By:
Page
of 69
The New England Journal of Medicine
|
November 7, 1996
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1
S C Rubin, I Benjamin, K Behbakht, et al.
Cancer Research Communications
|
March 5, 2024
Health Care Access Dimensions and Racial Disparities in End-of-Life Care Quality among Patients with Ovarian Cancer
Shama Karanth, Oyomoare L Osazuwa-Peters, Lauren E Wilson, et al.
Gynecologic Oncology
|
November 13, 2023
High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancer
Katherine E Baumann, Sharareh Siamakpour-Reihani, Joseph Dottino, et al.
Oncogene
|
October 7, 2008
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
T Baba, P A Convery, N Matsumura, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 25, 2007
A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer
J D Wright, A A Secord, T M Numnum, et al.
Journal of Minimally Invasive Gynecology
|
October 12, 2014
Vaginal cuff thermal injury by mode of colpotomy at total laparoscopic hysterectomy: a randomized clinical trial
Deanna Teoh, William J Lowery, Xiaoyin Jiang, et al.
JAMA
|
January 24, 2023
Predictive Accuracy of Stroke Risk Prediction Models Across Black and White Race, Sex, and Age Groups
Chuan Hong, Michael J Pencina, Daniel M Wojdyla, et al.
European Urology
|
April 23, 2021
Impact of Pathogenic Germline DNA Damage Repair alterations on Response to Intense Neoadjuvant Androgen Deprivation Therapy in High-risk Localized Prostate Cancer
Jacob E Berchuck, Zhenwei Zhang, Rebecca Silver, et al.
Gynecologic Oncology
|
May 21, 2005
BRAF polymorphisms and the risk of ovarian cancer of low malignant potential
Livia Kelemen, Michael James, Amanda Spurdle, et al.
Gynecologic Oncology
|
January 16, 2020
Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer
K Bixel, M Vetter, B Davidson, et al.
Page
of 69